Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.42M Hold
10,000
1.07% 28
2025
Q4
$2.82M Hold
10,000
1.18% 22
2025
Q3
$2.82M Hold
10,000
1.18% 22
2025
Q2
$2.95M Hold
10,000
1.3% 23
2025
Q1
$2.49M Hold
10,000
1.21% 22
2024
Q4
$2.2M Hold
10,000
1.05% 27
2024
Q3
$2.21M Hold
10,000
1.04% 30
2024
Q2
$1.73M Hold
10,000
0.87% 31
2024
Q1
$1.91M Hold
10,000
0.95% 29
2023
Q4
$1.64M Hold
10,000
0.88% 28
2023
Q3
$1.4M Hold
10,000
0.83% 30
2023
Q2
$1.34M Hold
10,000
0.75% 34
2023
Q1
$1.31M Hold
10,000
0.79% 33
2022
Q4
$1.41M Hold
10,000
0.9% 34
2022
Q3
$1.19M Hold
10,000
0.75% 34
2022
Q2
$1.41M Hold
10,000
0.85% 30
2022
Q1
$1.34M Hold
10,000
0.61% 37
2021
Q4
$1.34M Sell
10,000
-460
-4% -$57.7K 0.61% 37
2021
Q3
$1.33M Hold
10,460
0.65% 36
2021
Q2
$1.47M Hold
10,460
0.64% 36
2021
Q1
$1.33M Hold
10,460
0.61% 36
2020
Q4
$1.26M Hold
10,460
0.62% 35
2020
Q3
$1.22M Hold
10,460
0.74% 31
2020
Q2
$1.21M Hold
10,460
0.77% 28
2020
Q1
$1.11M Buy
+10,460
New +$1.32M 0.91% 26

Other funds holding IBM

Westport Asset Management's IBM Position: Q1 2026 in Review

Westport Asset Management held its IBM (IBM) position steady in Q1 2026 at 10,000 shares worth $2.42M. The position accounts for 1.07% of the portfolio, ranked #28.

Westport Asset Management first reported a position in IBM in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.95M in Q2 2025. 3,462 funds tracked by Wall St. Rank hold IBM as of Q1 2026.

  • Westport Asset Management held 10,000 shares of IBM worth $2.42M as of Q1 2026.
  • Westport Asset Management left its IBM share count unchanged in Q1 2026.
  • IBM made up 1.07% of Westport Asset Management's portfolio in Q1 2026, its #28 holding.
  • Westport Asset Management first reported a position in IBM in Q1 2020 and has held it in 25 quarters since.
  • Westport Asset Management's IBM position peaked at $2.95M in Q2 2025.
  • 3,462 funds tracked by Wall St. Rank held IBM as of Q1 2026.

Based on Westport Asset Management's 13F filing for Q1 2026, filed 15 May 2026.